These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30218507)

  • 41. A national survey of physician-industry relationships.
    Sade RM
    N Engl J Med; 2007 Aug; 357(5):507; author reply 508. PubMed ID: 17671263
    [No Abstract]   [Full Text] [Related]  

  • 42. Lunch with Lilly: who pays?
    Strong C
    Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499
    [No Abstract]   [Full Text] [Related]  

  • 43. Why academic medical centers should ban drug company gifts to individuals.
    Strong C
    Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327
    [No Abstract]   [Full Text] [Related]  

  • 44. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
    Huddle TS
    Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
    [No Abstract]   [Full Text] [Related]  

  • 45. [Conflict of interest regarding clinical physicians' relationship with pharmaceutical industry and medical education].
    Miyata Y
    Seishin Shinkeigaku Zasshi; 2010; 112(11):1136-45. PubMed ID: 21226250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Case: bioethical disputes of the donations of the pharmaceutical companies to the health centers].
    González-González A
    Cuad Bioet; 2020; 31(103):423-427. PubMed ID: 33375807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug companies and clinical psychology.
    Baker E; Newnes C; Myatt H
    Ethical Hum Sci Serv; 2003; 5(3):247-53. PubMed ID: 15139338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
    Barnes RK
    Med J Aust; 2010 Mar; 192(5):294-5. PubMed ID: 20306549
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
    Steinman MA; Schillinger D
    Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
    [No Abstract]   [Full Text] [Related]  

  • 50. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 51. Physicians Should Refuse Pharmaceutical Industry Gifts.
    Brown SR
    Am Fam Physician; 2021 Oct; 104(4):348-350. PubMed ID: 34652114
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Big pharma.
    Campo D
    Del Med J; 2007 Jun; 79(6):243-5. PubMed ID: 17621870
    [No Abstract]   [Full Text] [Related]  

  • 54. GSK nixing physician dollars: other companies not to follow suit.
    Berger E
    Ann Emerg Med; 2014 Jun; 63(6):19A-21A. PubMed ID: 24967442
    [No Abstract]   [Full Text] [Related]  

  • 55. Punjab Medical Council investigates doctors for alleged payments from drug companies.
    Pulla P
    BMJ; 2015 Oct; 351():h5655. PubMed ID: 26506834
    [No Abstract]   [Full Text] [Related]  

  • 56. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia.
    Wilson A
    Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745
    [No Abstract]   [Full Text] [Related]  

  • 57. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Doctors face compulsory system to declare gifts and hospitality from drug companies.
    O'Dowd A
    BMJ; 2015 Aug; 351():h4617. PubMed ID: 26311722
    [No Abstract]   [Full Text] [Related]  

  • 59. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
    Katz D; Caplan AL; Merz JF
    Am J Bioeth; 2003; 3(3):39-46. PubMed ID: 14594489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Financial incentives and the prescription of newer vaccines by doctors in India.
    Lodha R; Bhargava A
    Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.